Merck KGaA (MKGAF) reports robust Q4 results with significant growth across sectors, despite challenges in Life Science and ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Merck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look ...

Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

On March 4, 2025, filings revealed that CEO Stephane Bancel purchased 160,314 shares of MRNA stock between $31.04 and $31.53, ...

Detailed price information for Occidental Petroleum Corp (OXY-N) from The Globe and Mail including charting and trades.

Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") of a class action securities lawsuit. CLASS ...